Literature DB >> 11699221

Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression.

B Gu1, L P Dao, J Wiley.   

Abstract

The emigration of lymphocytes from blood into lymph nodes is regulated by the expression of the adhesion molecule, L-selectin on the lymphocyte surface which arrests the rolling of the cell on the vessel wall and allows firmer adhesive interactions to develop. The expression of L-selectin on B-CLL lymphocytes is less than half that on normal lymphocytes and this difference correlates with an impaired capacity of B-CLL lymphocytes to migrate beneath a monolayer of human umbilical vein endothelial cells. Both the B-cell and T-cell lymphocytes from normal subjects and B-CLL patients show down-regulation of L-selectin and CD23 after transendothelial migration. The reduced expression of L-selectin on B-CLL lymphocytes leads to a relative "trapping" of these cells in the vascular space and is one factor contributing to the elevation of peripheral lymphocyte count.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699221     DOI: 10.3109/10428190109097671

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration.

Authors:  Eva M Trinidad; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Cell Adh Migr       Date:  2010-07-22       Impact factor: 3.405

2.  Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.

Authors:  Carlos Cassano; Swetlana Mactier; Stephen P Mulligan; Larissa Belov; Pauline Huang; Richard I Christopherson
Journal:  Int J Proteomics       Date:  2010-05-05

3.  Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.

Authors:  Antonella Zucchetto; Paolo Sonego; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Pietro Bulian; Dania Benedetti; Maurizio Rupolo; Giovanni Del Poeta; Renato Campanini; Valter Gattei
Journal:  J Transl Med       Date:  2006-03-01       Impact factor: 5.531

4.  Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.

Authors:  Xue Yan Cui; Geir Erland Tjønnfjord; Sandip M Kanse; Anders Erik Astrup Dahm; Nina Iversen; Christiane Filion Myklebust; Ling Sun; Zhong Xing Jiang; Thor Ueland; James J Campbell; Mitchell Ho; Per Morten Sandset
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 5.  The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.

Authors:  Gabriele Brachtl; Josefina Piñón Hofbauer; Richard Greil; Tanja Nicole Hartmann
Journal:  Ann Hematol       Date:  2013-11-28       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.